Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Early Phase 1 Interventional Accepts healthy volunteers

[18F]ZDG2 First-in-Human PET Imaging in PAH

ClinicalTrials.gov ID: NCT07934264

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07934264. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 8:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

First-in-Human PET Imaging of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension Using [18F]ZDG2: Safety, Biodistribution, Dosimetry and Pharmacokinetics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to find out whether \[18F\]ZDG2 can detect early blood vessel changes in people with pulmonary arterial hypertension (PAH). The study will help answer this question: Can a positron emission tomography (PET) scan using \[18F\]ZDG2 help identify PAH? Participants will: * Receive one or two doses of the study tracer \[18F\]ZDG2 and have a PET/CT scan after each dose * Provide blood and urine samples * Tell the study team about any side effects or symptoms you experience

Study identification

NCT ID
NCT07934264
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Early Phase 1
Enrollment
20 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2026 (Estimated)
Primary completion
Apr 30, 2028 (Estimated)
Completion
Oct 31, 2028 (Estimated)
Last update posted
Nov 18, 2026

2026 – 2028

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Houston Methodist Research Institute Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07934264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.